Catalyst Wire Dossier Catalyst Wire Dossier

Sargramostim (GM-CSF) inhalation

granulocyte-macrophage colony-stimulating factor (GM-CSF)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sargramostim (GM-CSF) inhalation, covering 2023-06-26 to 2023-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Inhaled GM-CSF Therapy of Autoimmune PAP [Phase 2]

See pricing